CA2761258C — Antiviral compounds
Assigned to Gilead Sciences Inc · Expires 2015-08-04 · 11y expired
What this patent protects
The invention relates to anti-viral compounds, compositions containing such compounds, and therapeutic uses of such compounds, as well as to processes and intermediates useful for preparing such compounds. Representative compounds include compounds of formula I: (see formula I)
USPTO Abstract
The invention relates to anti-viral compounds, compositions containing such compounds, and therapeutic uses of such compounds, as well as to processes and intermediates useful for preparing such compounds. Representative compounds include compounds of formula I: (see formula I)
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.